Condition
CAD - Coronary Artery Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 6 CAD - Coronary Artery Disease clinical trials that are recruiting, at sites in 5 countries (most in Russia (2), Uzbekistan (1), Lebanon (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest CAD - Coronary Artery Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SiroMax sirolimus-coated balloon for small coronary vessels with or without prior stents | — | Tashkent and 1 other locations | Recruiting | Sep 9, 2026 |
| Predicting major heart problems after coronary artery bypass grafting in people with heart failure | — | Tomsk, Tomsk Oblast | Recruiting | Mar 18, 2026 |
| Pain relief after CABG: tafalgin versus morphine | — | Vladivostok, Outside US | Recruiting | Mar 5, 2026 |
| SirPlux Duo dual-API drug-coated balloon to treat new and in‑stent coronary blockages | — | Barcelona and 2 other locations | Recruiting | Jan 27, 2026 |
| Empagliflozin to reduce inflammation after coronary stenting | Phase 4 | Beirut, Beirut | Recruiting | Dec 18, 2025 |
| Outcomes after PCI using the Protégé paclitaxel drug-coated balloon. | — | Amsterdam | Recruiting | Nov 17, 2025 |
All recruiting trials (6)
-
SiroMax sirolimus-coated balloon for small coronary vessels with or without prior stents
A first-in-human test to see if the SiroMax drug-coated balloon can safely open narrow coronary arteries in adults with or without prior stents.
-
Predicting major heart problems after coronary artery bypass grafting in people with heart failure
This study will test whether a blood marker called GDF-15 taken before bypass surgery can help predict major heart events over the year after CABG in patients with chronic heart failure and coronary artery disease.
-
Pain relief after CABG: tafalgin versus morphine
This will test whether tafalgin relieves pain after coronary artery bypass surgery as well as morphine in adult patients.
-
SirPlux Duo dual-API drug-coated balloon to treat new and in‑stent coronary blockages
This study tests the SirPlux Duo drug‑coated balloon in adults with symptomatic coronary artery disease who have either new (de novo) small vessel blockages or in‑stent restenosis to see if it is safe and works well.
-
Empagliflozin to reduce inflammation after coronary stenting
This trial will test whether taking empagliflozin for three days before elective PCI reduces the rise in C‑reactive protein and other inflammatory markers in people with stable coronary artery disease.
-
Outcomes after PCI using the Protégé paclitaxel drug-coated balloon.
This registry will collect real-world data to see if the Protégé paclitaxel drug-coated balloon works well and is safe for adults having PCI for coronary artery disease or acute coronary syndrome.
Related topics
Quick answers
How many CAD - Coronary Artery Disease clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Russia (2 trials), Uzbekistan (1 trial), Lebanon (1 trial), Spain (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.